#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaplastic large cell lymphoma T- and null-cell types Chordoma Erythema White matter lesion Behcet's syndrome Myxoid liposarcoma Paget's disease of the vulva Thyroid cancer metastatic Choroidal dystrophy Nephroblastoma Marfan's syndrome Amyotrophic lateral sclerosis gene carrier Hidradenitis Pyruvate kinase deficiency anaemia Cholangiosarcoma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Basic Information Progressive multifocal leukoencephalopathy – Treatment Marginal zone lymphoma refractory – Basic Information Alagille syndrome – Trials in Disease Rett syndrome – Treatment Synovial sarcoma metastatic – Diagnostics Hepatic angiosarcoma – Treatment Marfan’s syndrome – Treatment Ocular melanoma Vascular malformation More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ulotaront Procarbazine Zenocutuzumab Eliglustat Tartrate Divarasib Rezafungin Acetate Valganciclovir Hydrochloride Artemisia Vulgaris (312) Daunorubicin Hydrochloride [11C]Az14193391 Amifostine Thiol Gskvx000000017033 Midostaurin RNMB1 Vx-522 Mva-209-Fsp-B1 LY3372993 4-Hydroxy-N-Desmethyltamoxifen Ibuprofen Sodium Dihydrate [18F] CANAGLIFLOZIN More therapies…

    Learn about Your Condition

    Richter's syndrome Anxiety Growth hormone deficiency Acute myeloid leukaemia Gastrointestinal melanoma Enteritis Leukaemia Fibrous dysplasia of bone Cutaneous calcification Bacterial prostatitis Behcet's syndrome Acute leukaemia Acute on chronic liver failure Hyperoxaluria Tendon disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-Hodgkin’s lymphoma refractory

  • Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Non-Hodgkin’s lymphoma refractory
    Investigated Drugs:
    • T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
    Germany

  • Study on the Safety of HSP-CAR30 Immunotherapy for Patients with Relapsed or Refractory CD30+ Hodgkin and Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    • Non-Hodgkin’s lymphoma refractory
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • HSP-CAR30
    • Cyclophosphamide Monohydrate
    • Bendamustine Hydrochloride
    Spain

  • Study on the Safety and Effectiveness of Brexucabtagene Autoleucel for Children and Teens with Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma refractory
    • B-cell type acute leukaemia
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    Czechia France Germany Italy Poland Spain

  • Study on the Safety and Effects of IPH6501 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Iph6501
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!